Description
Next Generation Sequencing Markets (Instrumentation, Consumables, Services, Competitive Analysis, Trends)
Next generation sequencing (NGS) technologies encompass the modern, post-Sanger sequencing techniques that revolutionized and expanded the fields of molecular biology and genomics in recent years. NGS has been a disruptive technology that had a substantial impact on the characterization of the genome of various species, and has found numerous applications in a large variety of fields, including clinical diagnostics, drug discovery and development, agriculture, and forensics. Next Generation Sequencing Markets provides an in-depth look at the sequencing market, including for 2016-2022 the world NGS sequencing and Sanger sequencing technologies markets for 2016-2022 and the world NGS market for services, instruments, and consumables for 2016-2022. The report also provides financial trends by geographic regions, breaking down the world 2016-2022 NGS market by United States, Europe, Asia/Pacific, and rest of world segments.
Examination of the research segment versus the clinical use segment and a breakdown of the current clinical sequencing market by disease category are also provided in Next Generation Sequencing Markets. Agilent Technologies, BD Biosciences, Illumina, Roche,and Thermo Fisher Scientific are among the major manufacturers of NGS instrumentation or consumables profiled in the report.
